at 8 d of age or older. Percentage of triglycerides in the total lipids of the liver and plasma increased progressively in the hypoxic newborn rats (Table 1) but beta-hydroxybutyrate and acetoacetate blood levels were normal for the age. Liver glycogen stores were depleted in the hypoxic suckling rats with fatty liver. When hypoxic rats were returned to sea level pressure for 8, 24, and 48 h before sacrifice, the level of total lipids in plasma and liver decreased, and the beta-hydroxybutyrate blood level increased significantly. Total liver lipids fell to normal values in the litter kept at sea level pressure for 24 h. Carbon monoxide produced similar results.
The fact that the rat is the only known species to show hypoxic impairment of the lipid metabolism with severe fatty liver degeneration in the perinatal period supports the existence of an unique type of lipid metabolism. Hypoxia could serve as a tool to unravel the characteristics of this apparently unique type of lipid metabolism. The excellent review by Brasel (I), "Endocrine Adaptation to Malnutrition" is a thorough attempt to look for generalities in a confusing field. It is possible that one of the points of confusion Brasel leaves unresolved contains within it information that may help to reduce the confusion, and suggests a need for greater liason between investigators.
Brasel points out that studies on growth hormone in malnutrition generally report high levels of this hormone, with excep tions, in cases where growth hormone levels were originally normal or diminished. The studies of Monckeberg et al. ) and Godard (5) indicate that this rate of change, shown during recovery, is significantly related to growth hormone levels. It would help in the interpretation of all results on malnourished children if clinical status could be specified more precisely than is possible by currently accepted anthropometric dassifi&-tion schemes. or bv traditional clinical divisions into named disease states.' It wobld be illogical to ask that only growth rates should be given, although they are clearly important. It is also reasonable to assume that food intakes would be important determinants of hormonal profile, and also that patients can be not only recovering, but if studied early enough after the initiation of malnutrition, their hormonal profile may also reflect their rate of deterioration.
It is difficult to see how coherence can be obtained. Is it unreasonable to suggest a discussion among principal investigators is needed to agree on an ideal list of clinical data for any malnourished child studied, and to propose the requirement for a single archive where copies of such new data could be lodged by all investigators, and made accessible to all workers in the field, permitting more easily the detection of trends of the type reported by Monckeberg el al. I completely agree with Dr. Robinson that much of the difficulty in evaluating the data on growth hormone levels in malnutrition is related to the fact that the subjects are often in differing states of malnutrition and/or recovery. It would have been very helpful to me in my review if the types of additional information on the patients and their condition, which is mentioned in the letter, had been available. I can only support the proposal that investigators in the field develop a format for recording such data for the use of others with great enthusiasm. Good luck!
Letter to the Editor

MAURICE COHEN
Wyeth Laboratories, Taplow, Maidenhead. Berkshire, England I have just read the paper in your journal by Sampson et al. "Manganese Balance Studies in Infants after Operations on the Heart" 17: 263 (1983). There are one or two points that need correction. In Table 4 on page 264, it should be noted that both S26 and SMA are manufactured by Wyeth. The levels of manganese quoted for these two products are stated to be low, and if nmole/litre is converted to &litre the values would read: S26 -14.8 + 7.7 and range, 5.8-63; and SMA -11.8 k 7.7 and range 3.8-23. In fact our present label claim is 160 pg per reconstituted litre, a level significantly greater than the Sampson analysis.
As fortification of our nutritional products with manganese was introduced in September 1977, the levels quoted in the article must be associated with unfortified products manu- We read with interest the comments by Mr. Cohen on our paper "Manganese Balance Studies on Infants After Operations THE EDITOR 30 1 on the Heart" and regret the confusion that led us to incorrectly ascribing the manufacture of some of the milk products used. The clinical treatments on which this study was based were commenced in 197415 and completed in 1978. Most of the samples analysed were stored frozen until analysed. It is thus probable that most of the patients studied will have been treated in the period before the supplemented milk products became available. It is not possible at this stage to say which patients may have received the supplemented product.
It is unlikely that a study conducted using supplemented milk would have led to markedly differing conclusions on the need for manganese supplementation in the surgical neonate. The ready availability of such a product will hopefully obviate the need for any further supplementation of such patients with manganese.
